Hospital
Avera ST Marys
Avera ST Marys was paid $1.65M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.
33Billing provider infoAVERA ST MARYS
PIERRE, SD 57501
PIERRE, SD 57501
33aNPI1669457180assigned 12/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.65M
24GClaims42,327
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Dakota
Rank by total paid#7 of 17
Median peer was paid$547K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,117 | $228K | |
| 2019 | 6,625 | $271K | |
| 2020 | 3,163 | $115K | |
| 2021 | 6,377 | $229K | |
| 2022 | 6,276 | $191K | |
| 2023 | 6,498 | $279K | |
| 2024incomplete | 6,271 | $336K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 8,897 | 7,315 | $456K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 4,384 | 3,476 | $325K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 13% | 15,442 | 5,013 | $209K |
| J3490 | Unclassified drugs | 12% | 2,200 | 1,318 | $195K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 1,677 | 1,326 | $193K |
| A9270 | Non-covered item or service | 5.1% | 2,431 | 442 | $83K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 1,301 | 1,149 | $36K |
| 80053 | Comprehensive metabolic panel | 1.6% | 239 | 217 | $27K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 589 | 579 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 144 | 144 | $18K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 158 | 149 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,463 | 142 | $15K |
28 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 46 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 612 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 258 | $5K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 778 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 81 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 108 | $3K |
| Q3014 | Telehealth originating site facility fee | <1% | 105 | $3K |
| 36416 | <1% | 45 | $2K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 14 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 66 | $1K |
| 01480 | <1% | 21 | $1K | |
| 81001 | <1% | 27 | $1K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 73 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 32 | $984.58 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 12 | $750.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 12 | $721.10 |
| G0008 | Administration of influenza virus vaccine | <1% | 120 | $685.42 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 45 | $668.31 |
| 11721 | <1% | 26 | $342.04 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 507 | $335.81 |
| 87081 | <1% | 218 | $36.18 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 58 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 16 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 53 | $0.00 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 14 | $0.00 |
| 90656 | 0% | 12 | $0.00 | |
| 86140 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLLAND, MIKEL (CEO/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Avera ST. Mary's | Pierre, SD | $319K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.